Patienthèque of Finisterian (South of Brittany) Children With Cystic Fibrosis in the Time of Precision Medicine

Recruiting now · Not applicable

Conditions studied: Cystic Fibrosis

In brief

The objective of this study is to evaluate the relevance of Porphyromonas as a biomarker predicting the risk of P. aeruginosa primocolonization in children form 0 to 18 years old with cystic fibrosis.

Key facts

Study ID

NCT04137133

Run by

University Hospital, Brest

People needed

20

Starts

2022-03-21

Expected to finish

2030-03-01

Last updated by the study team

2024-04-23

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Newly screened infants with a confirmed diagnosis of cystic fibrosis in its classic form (clinical symptoms and two positive sweat tests and/or two mutations of the cftr gene from Class I to III)
• Children free of any colonization with P. aeruginosa
• Affiliation with the social security system
• Consent signed by the holders of parental authority or the sole parent holding parental authority

You may not qualify if…

• Children colonized with P. aeruginosa according to the cytobacteriological examination and / or molecular test of sputum or pharyngeal specimens
• Children grafted
• Children not affiliated to a social security scheme or not entitled to
• Children whose parent (s) are (are) minor (s)
• Children whose holders of parental authority do not master the French language
• Refusal to participate in the study

Where it is running

• Fondation Ildys — Roscoff, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.